-
1.
公开(公告)号:US20240358644A1
公开(公告)日:2024-10-31
申请号:US18528153
申请日:2023-12-04
申请人: Flurry Powders, LLC
IPC分类号: A61K9/16 , A61K9/00 , A61K31/05 , A61K31/352 , A61K36/00
CPC分类号: A61K9/1694 , A61K9/0075 , A61K9/1617 , A61K9/1652 , A61K31/05 , A61K31/352 , A61K36/00
摘要: A method of manufacturing a flowable and dispersible powder includes solubilizing a lipophilic substance in a terpene to form a mixture and treating the mixture to form a nanoemulsion dispersed in an aqueous solution. The aqueous solution includes at least one functional excipient. The nanoemulsion is then spray dried, thereby evaporating first the aqueous portion and then the terpene to form a dry powder formed from solid particles comprising the lipophilic substance.
-
公开(公告)号:US20240342100A1
公开(公告)日:2024-10-17
申请号:US18421205
申请日:2024-01-24
申请人: Soane Pharma LLC
CPC分类号: A61K9/4816 , A61K9/0053 , A61K9/4808 , A61K35/12 , A61K36/00 , A61K38/00
摘要: The invention includes an orally ingestible delivery system for releasing a therapeutic agent within an intestine of a mammal, where the system includes the therapeutic agent and a differentially permeable capsule system containing the therapeutic agent within a therapeutic agent compartment, with the differentially permeable capsule system dimensionally adapted for oral ingestion and for passage into a stomach of the mammal and thence into the intestine, wherein the differentially permeable capsule system comprises an acid-resistant shell and a dispersible acid barrier, wherein the dispersible acid barrier forms while the orally-ingestible delivery system is in the stomach; and wherein the dispersible acid barrier is dispersed in the intestine, thereby permitting enzymes in the intestine to reach the therapeutic agent compartment. The invention also includes methods of manufacturing the system and methods for its use.
-
3.
公开(公告)号:US12090230B2
公开(公告)日:2024-09-17
申请号:US17979346
申请日:2022-11-02
发明人: Jordan Seth Rubin
IPC分类号: A61K36/00 , A23L33/105 , A23L33/135 , A23L33/21 , A23P10/30 , A61K9/00 , A61K9/20 , A61K9/48 , A61K36/185 , C12N1/20 , A61K31/352
CPC分类号: A61K9/20 , A23L33/105 , A23L33/135 , A23L33/21 , A23P10/30 , A61K9/0053 , A61K9/48 , A61K36/185 , C12N1/20 , A61K31/352
摘要: The present invention is a cannabidiol oral dosage form including predominantly or exclusively bacterially fermented hemp pomace, compounded as a tablet or formulated within a capsule generally without the addition of synthetic excipients, fillers or other additives, not including the inevitable presence of some moisture. The dosage forms contain dietary fiber, important to activity as the desired delivery system, having a ratio of one part soluble dietary fiber to 30 parts insoluble dietary fiber and delivers desirable/non hallucinogenic cannabinoids (CBD, CBG, etc.) in a ratio of 60:1 up to 120:1 to hallucinogenic cannabinoids (THC).
-
公开(公告)号:US12090186B2
公开(公告)日:2024-09-17
申请号:US17222768
申请日:2021-04-05
发明人: Karen Vieira , John Britto
IPC分类号: A61K36/00 , A61K9/00 , A61K9/48 , A61K31/4525 , A61K35/04 , A61K35/74 , A61K35/748 , A61K36/185 , A61K36/31 , A61K36/47 , A61K36/48 , A61K36/53 , A61K36/61 , A61K36/67 , A61K36/9066 , A61P3/06 , A61P3/10 , A61P39/06
CPC分类号: A61K36/31 , A61K9/0053 , A61K9/48 , A61K31/4525 , A61K35/04 , A61K35/74 , A61K35/748 , A61K36/185 , A61K36/47 , A61K36/48 , A61K36/53 , A61K36/61 , A61K36/67 , A61K36/9066 , A61P3/06 , A61P3/10 , A61P39/06 , A61K2300/00 , A61K2300/00 , A61K36/185 , A61K2300/00 , A61K36/47 , A61K2300/00 , A61K36/48 , A61K2300/00 , A61K36/53 , A61K2300/00 , A61K36/67 , A61K2300/00 , A61K36/9066 , A61K2300/00 , A61K35/74
摘要: The main objective of the present invention is to develop an herbal formulation with high polyphenol concentrations. A therapeutic effect of ingredients in herbal composition with Antioxidants, Anti-inflammatories, Anti Viral & Anti Microbial properties to reduce Oxidative Stress, Inflammation, Viral and Microbial Infections. The herbal composition promotes management of diabetes, regulation of cholesterol, also immune system processes that helps to fight against viral and bacterial infections, colds, or the flu, skin ailments such as Psoriasis & eczema. Herbal Composition comprises synergistic combination of Moringa oleifera Leaf Powder, Spirulina & Aqueous extracts of Oregano vulgare Leaf Extract, Shilajit extract, Rosemary Leaf extract, Pomegranate Fruit Preel extract, Amla fruit extract, Fenugreek Seed Extract, Curcumin Extract, Piperine extract. Therefore, the chosen herbal blend provides the body with all of the vitamins, minerals, and nutrients it needs to continuously boost health.
-
公开(公告)号:US12083155B2
公开(公告)日:2024-09-10
申请号:US17383368
申请日:2021-07-22
发明人: Mark Margulies , Dennis L. Zak
IPC分类号: A61K36/889 , A23D9/00 , A61K36/00 , A61K36/185 , A61K36/28 , A61K36/31 , A61K36/48 , A61K36/63 , A61K36/87 , A61K45/06
CPC分类号: A61K36/889 , A23D9/00 , A61K36/185 , A61K36/28 , A61K36/31 , A61K36/48 , A61K36/63 , A61K36/87 , A61K45/06 , A61K36/28 , A61K2300/00 , A61K36/63 , A61K2300/00 , A61K36/185 , A61K2300/00 , A61K36/889 , A61K2300/00 , A61K36/48 , A61K2300/00 , A61K36/31 , A61K2300/00 , A61K36/87 , A61K2300/00
摘要: A composition includes at least one edible oil for treating oral complications and providing nutrition by administering such composition.
-
公开(公告)号:US12059671B2
公开(公告)日:2024-08-13
申请号:US17195443
申请日:2021-03-08
申请人: CRESCO LABS LLC
发明人: David Sanchez
IPC分类号: A61K36/00 , A61K36/185 , B01J3/06
CPC分类号: B01J3/062 , A61K36/185
摘要: A cannabis oil formulation comprises a level of terpene concentration of at least 4.88% by weight, detectable levels of tetrahydrocannabinol (THC) and at least two other cannabinoids, and a level of tetrahydrocannabinolic acid (THCA) concentration that is not detectable.
-
公开(公告)号:US12053499B1
公开(公告)日:2024-08-06
申请号:US18429310
申请日:2024-01-31
IPC分类号: A61K36/00 , A61K36/899 , A61K45/06 , A61K47/69
CPC分类号: A61K36/899 , A61K45/06 , A61K47/6929 , A61K2236/15 , A61K2236/333
摘要: A composition for treating osteoporosis comprising Acroceras macrum gold nanoparticles (AM-AuNPs). The composition is prepared by mixing an Acroceras macrum extract with an aqueous chloroauric acid (HAuCl4) solution to provide a mixture including the Acroceras macrum gold nanoparticles; removing unreacted Acroceras macrum extract from the mixture followed by purifying the Acroceras macrum gold nanoparticles; and obtaining the gold nanoparticle composition comprising the Acroceras macrum gold nanoparticles (AM-AuNPs). The composition may be used to form drug compositions for treating osteoporosis.
-
公开(公告)号:US12053437B2
公开(公告)日:2024-08-06
申请号:US17448517
申请日:2021-09-22
发明人: James Stringham
IPC分类号: A61K36/00 , A61K31/065 , A61K31/202 , A61K31/341 , A61K31/355 , A61K33/30 , A61K35/60 , A61K35/644 , A61K36/28 , A61K36/48 , A61K47/42 , A61P27/02
CPC分类号: A61K31/065 , A61K31/202 , A61K31/341 , A61K31/355 , A61K33/30 , A61K35/60 , A61K35/644 , A61K36/28 , A61K36/48 , A61K47/42 , A61P27/02
摘要: An eye health supplement and methods of using the eye health supplement are disclosed.
-
公开(公告)号:US12053436B2
公开(公告)日:2024-08-06
申请号:US17448513
申请日:2021-09-22
发明人: James Stringham
IPC分类号: A61K36/00 , A61K31/065 , A61K31/202 , A61K31/341 , A61K31/355 , A61K33/30 , A61K35/60 , A61K35/644 , A61K36/28 , A61K36/48 , A61K47/42 , A61P27/02
CPC分类号: A61K31/065 , A61K31/202 , A61K31/341 , A61K31/355 , A61K33/30 , A61K35/60 , A61K35/644 , A61K36/28 , A61K36/48 , A61K47/42 , A61P27/02
摘要: An eye health supplement and methods of using the eye health supplement are disclosed.
-
公开(公告)号:US12042523B2
公开(公告)日:2024-07-23
申请号:US18084009
申请日:2022-12-19
申请人: Unigen, Inc.
发明人: Qi Jia , Ping Jiao , Mesfin Yimam , Teresa Horm
IPC分类号: A61K36/00 , A61K31/352 , A61K31/353 , A61K31/7034 , A61K36/48 , A61K36/605
CPC分类号: A61K36/605 , A61K31/352 , A61K31/353 , A61K31/7034 , A61K36/48 , A61K2300/00 , A61K36/605 , A61K2300/00 , A61K36/48 , A61K2300/00 , A61K31/352 , A61K2300/00 , A61K31/7034 , A61K2300/00 , A61K31/353 , A61K2300/00
摘要: Compositions and methods for bone health, cartilage health or both, are disclosed that include preparing and utilizing a mixture of at least one Morus extract enriched for one or more prenylated flavonoids, at least one Scutellaria extract enriched for one or more free-B-ring flavonoids, and at least one Acacia extract enriched for one or more flavans.
-
-
-
-
-
-
-
-
-